Search research articles
Contact Us
Filters
Showing results (881-890 of 934) with videos related to
Page
of 94
Sort By:
JAMA Cardiology
|
May 19, 2021
Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction: The Mass General Brigham YOUNG-MI Registry
Adam N Berman, David W Biery, Curtis Ginder, et al.
European Journal of Preventive Cardiology
|
October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic Disease
Andre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
Journal of the American College of Cardiology
|
September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Ankeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
European Heart Journal
|
August 23, 2021
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
Brendon L Neuen, Megumi Oshima, Vlado Perkovic, et al.
American Heart Journal
|
December 28, 2020
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
Ashish Sarraju, JingWei Li, Christopher P Cannon, et al.
Kidney International
|
December 14, 2020
Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice
Megumi Oshima, Meg J Jardine, Rajiv Agarwal, et al.
Population Health Management
|
December 4, 2024
Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy
Samantha Subramaniam, Shahzad Hassan, Ozan Unlu, et al.
Obesity (Silver Spring, Md.)
|
December 19, 2024
Contemporary treatment patterns of overweight and obesity: insights from the Mass General Brigham health care system
John W Ostrominski, Kavishwar B Wagholikar, Kelly Olsson, et al.
Journal of the American Heart Association
|
September 2, 2017
Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
Ralph A H Stewart, Emil Hagström, Claes Held, et al.
JAMA
|
April 5, 2008
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial
Steven E Nissen, Stephen J Nicholls, Kathy Wolski, et al.
Page
of 94
Search research articles
Search
Showing results (881-890 of 934) with videos related to
Sort By:
Page
of 94
JAMA Cardiology
|
May 19, 2021
Association of Socioeconomic Disadvantage With Long-term Mortality After Myocardial Infarction: The Mass General Brigham YOUNG-MI Registry
Adam N Berman, David W Biery, Curtis Ginder, et al.
European Journal of Preventive Cardiology
|
October 28, 2025
Polygenic Risk Score for Coronary Artery Disease Across the Spectrum of Atherosclerotic Disease
Andre Zimerman, Frederick K Kamanu, Giorgio E M Melloni, et al.
Journal of the American College of Cardiology
|
September 11, 2024
Effects of Sotagliflozin on Health Status in Patients With Worsening Heart Failure: Results From SOLOIST-WHF
Ankeet S Bhatt, Deepak L Bhatt, Ph Gabriel Steg, et al.
European Heart Journal
|
August 23, 2021
Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: the CREDENCE trial
Brendon L Neuen, Megumi Oshima, Vlado Perkovic, et al.
American Heart Journal
|
December 28, 2020
Effects of canagliflozin on cardiovascular, renal, and safety outcomes in participants with type 2 diabetes and chronic kidney disease according to history of heart failure: Results from the CREDENCE trial
Ashish Sarraju, JingWei Li, Christopher P Cannon, et al.
Kidney International
|
December 14, 2020
Insights from CREDENCE trial indicate an acute drop in estimated glomerular filtration rate during treatment with canagliflozin with implications for clinical practice
Megumi Oshima, Meg J Jardine, Rajiv Agarwal, et al.
Population Health Management
|
December 4, 2024
Identifying Patients with Heart Failure Eligible for Guideline-Directed Medical Therapy
Samantha Subramaniam, Shahzad Hassan, Ozan Unlu, et al.
Obesity (Silver Spring, Md.)
|
December 19, 2024
Contemporary treatment patterns of overweight and obesity: insights from the Mass General Brigham health care system
John W Ostrominski, Kavishwar B Wagholikar, Kelly Olsson, et al.
Journal of the American Heart Association
|
September 2, 2017
Self-Reported Health and Outcomes in Patients With Stable Coronary Heart Disease
Ralph A H Stewart, Emil Hagström, Claes Held, et al.
JAMA
|
April 5, 2008
Effect of rimonabant on progression of atherosclerosis in patients with abdominal obesity and coronary artery disease: the STRADIVARIUS randomized controlled trial
Steven E Nissen, Stephen J Nicholls, Kathy Wolski, et al.
Page
of 94